Ultragenyx Pharmaceutical Statistics
NASDAQ: RAREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
15.29+0.40 (+2.69%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ultragenyx Pharmaceutical by the numbers
Ultragenyx Pharmaceutical has a market capitalization of $1.51 billion based on 98.59M shares outstanding. With trailing EPS of $-5.82, Ultragenyx Pharmaceutical is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.6% below its 50-day average and 35.5% below its 200-day average.
Average daily trading volume is 3.87M shares, or about $59.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RARE valuation vs. peer median
| Metric | RARE | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.51B | $1.52B | -1% |
| Forward P/E | 22.6 | 10.1 | +123% |
| Avg. volume | 3.87M | 837.08K | +362% |
Peer median across 8 companies: INVA, SNDX, PAHC, KRSA, STOK, PCRX, QURE, ETON.
Valuation
- Market cap
- $1.51B
- Forward P/E
- 22.59
- Price / sales (latest FY)
- 2.24
- EPS (TTM)
- $-5.82
- Shares outstanding
- 98.59M
Price and trading
- Previous close
- 14.89
- Open
- 14.79
- Day range
- 14.44 – 15.52
- 52-week range
- 12.73 – 39.89
- 52-week change
- -50.45%
- Beta
- —
- Volume
- 5.40M
- Average volume
- 3.87M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 1.51B
- Forward Pe
- 22.59
- Eps
- -5.82
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 39.89
- Week52 Low
- 12.73
- Avg Volume
- 3.87M
- Shares Outstanding
- 98.59M
- Ma50
- 20.28
- Ma200
- 23.71
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -61.67%
- Pct From52w Low
- 20.11%